⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1715476 | 0.95 | EPHX1 (0.58) | — | |
| SCHEMBL19532631 | 0.92 | EPHX1 (0.62) | — | |
| SCHEMBL1698394 | 0.92 | EPHX1 (0.62) | — | |
| SCHEMBL2465665 | 0.89 | — | — | |
| SCHEMBL22081106 | 0.83 | EPHX1 (0.42) | — | |
| SCHEMBL22081110 | 0.83 | EPHX1 (0.42) | — | |
| SCHEMBL22081107 | 0.83 | EPHX1 (0.42) | — | |
| SCHEMBL22081109 | 0.83 | EPHX1 (0.42) | — | |
| SCHEMBL22081092 | 0.83 | EPHX1 (0.42) | — | |
| SCHEMBL22081108 | 0.83 | EPHX1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2007511491-A | — | — | 2007-05-10 | — | — | JP | claimed |
| EP-1685116-A1 | QUINAZOLINE DERIVATIVES | AstraZeneca AB (SE) | 2006-08-02 | — | — | EP | claimed |
| WO-2005051923-A1 | QUINAZOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2005-06-09 | — | — | WO | claimed |
| EP-4251616-A1 | HETEROCYCLE DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS | Katholieke Universiteit Leuven (BE) | 2023-10-04 | — | — | EP | disclosed |
| WO-2022112352-A1 | HETEROCYCLE DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2022-06-02 | — | — | WO | disclosed |